BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26486866)

  • 1. Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke.
    Kraft P; Schuhmann MK; Fluri F; Lorenz K; Zernecke A; Stoll G; Nieswandt B; Kleinschnitz C
    Stroke; 2015 Dec; 46(12):3502-6. PubMed ID: 26486866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of platelet glycoprotein receptor Ib reduces "thrombo-inflammation" in mice with acute ischemic stroke.
    Schuhmann MK; Guthmann J; Stoll G; Nieswandt B; Kraft P; Kleinschnitz C
    J Neuroinflammation; 2017 Jan; 14(1):18. PubMed ID: 28109273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report.
    De Meyer SF; Schwarz T; Deckmyn H; Denis CV; Nieswandt B; Stoll G; Vanhoorelbeke K; Kleinschnitz C
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1949-51. PubMed ID: 20616311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
    Kraft P; Drechsler C; Gunreben I; Heuschmann PU; Kleinschnitz C
    PLoS One; 2015; 10(3):e0119810. PubMed ID: 25748430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.
    Choudhri TF; Hoh BL; Zerwes HG; Prestigiacomo CJ; Kim SC; Connolly ES; Kottirsch G; Pinsky DJ
    J Clin Invest; 1998 Oct; 102(7):1301-10. PubMed ID: 9769322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice.
    Schuhmann MK; Kraft P; Bieber M; Kollikowski AM; Schulze H; Nieswandt B; Pham M; Stegner D; Stoll G
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke.
    Wichaiyo S; Parichatikanond W; Rattanavipanon W
    Stroke; 2022 Nov; 53(11):3506-3513. PubMed ID: 36128904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.
    Berger PB; Best PJ; Topol EJ; White J; DiBattiste PM; Chan AW; Kristensen SD; Herrmann HC; Moliterno DJ
    Am Heart J; 2005 May; 149(5):869-75. PubMed ID: 15894970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotics and thrombolytics in stroke.
    Mousa SA; Iqbal O; Fareed J
    Curr Opin Investig Drugs; 2002 Jun; 3(6):878-85. PubMed ID: 12137407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab')2 in a model of focal cerebral ischemia in rats.
    Yang Y; Li Q; Nakada MT; Yang T; Shuaib A
    J Neurosurg; 2001 Apr; 94(4):582-8. PubMed ID: 11302656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla.
    Pham M; Helluy X; Kleinschnitz C; Kraft P; Bartsch AJ; Jakob P; Nieswandt B; Bendszus M; Stoll G
    PLoS One; 2011 Apr; 6(4):e18386. PubMed ID: 21483769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.
    Stoll G; Kleinschnitz C; Nieswandt B
    Blood; 2008 Nov; 112(9):3555-62. PubMed ID: 18676880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.